ARTICLE | Clinical News
Ramucirumab regulatory update
July 30, 2012 7:00 AM UTC
The European Commission granted Orphan Drug designation for Eli Lilly's ramucirumab to treat gastric cancer and hepatocellular carcinoma. The human mAb VEGF receptor 2 ( KDR/Flk-1; VEGFR-2) antagonis...